Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Poulin

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Journal of Pharmaceutical Sciences|May 25, 2025
Which unbound fraction should we use in the well-stirred model for more accurately predicting hepatic clearance of drugs for humans?Patrick Poulin
Journal of Pharmaceutical Sciences|April 25, 2013
Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugsPatrick Poulin
Journal of Pharmaceutical Sciences|May 25, 2024
First-in-Human Predictions of Hepatic Clearance for Drugs With the Well-Stirred Model: Comparative Assessment Between Models of Fraction Unbound Based Either on the Free Drug Hypothesis, Albumin-Facilitated Hepatic Uptake or Dynamic Binding KineticsPatrick Poulin
Clinical Pharmacokinetics|September 8, 2011
A single-species approach considering additional physiological information for prediction of hepatic clearance of glycoprotein derivate therapeuticsPatrick Poulin
Journal of Pharmaceutical Sciences|May 7, 2015
A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug designPatrick Poulin
Journal of Pharmaceutical Sciences|September 12, 2024
An overview of interpretability of two models of unbound fraction that are used in combination with the well-stirred model for predicting hepatic clearance of drugsPatrick Poulin
Journal of Pharmaceutical Sciences|March 27, 2015
Drug Distribution to Human Tissues: Prediction and Examination of the Basic Assumption in In Vivo Pharmacokinetics-Pharmacodynamics (PK/PD) ResearchPatrick Poulin
Talanta|December 17, 2008
Determination of ammonium using a microplate-based fluorometric techniquePatrick Poulin, Emilien Pelletier
Journal of Pharmaceutical Sciences|May 15, 2013
Hepatocyte composition-based model as a mechanistic tool for predicting the cell suspension: aqueous phase partition coefficient of drugs in in vitro metabolic studiesPatrick Poulin, Sami Haddad
Regulatory Toxicology and Pharmacology : RTP|November 7, 2017
Integration of a plasma protein binding factor to the Chemical-Specific Adjustment Factor (CSAF) for facilitating the estimation of uncertainties in interspecies extrapolations when deriving health-based exposure limits for active pharmaceutical ingredients: Investigation of recent drug datasetsPatrick Poulin, Richard Arnett
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Journal of Pharmaceutical Sciences|May 25, 2025
Which unbound fraction should we use in the well-stirred model for more accurately predicting hepatic clearance of drugs for humans?Patrick Poulin
Journal of Pharmaceutical Sciences|April 25, 2013
Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugsPatrick Poulin
Journal of Pharmaceutical Sciences|May 25, 2024
First-in-Human Predictions of Hepatic Clearance for Drugs With the Well-Stirred Model: Comparative Assessment Between Models of Fraction Unbound Based Either on the Free Drug Hypothesis, Albumin-Facilitated Hepatic Uptake or Dynamic Binding KineticsPatrick Poulin
Clinical Pharmacokinetics|September 8, 2011
A single-species approach considering additional physiological information for prediction of hepatic clearance of glycoprotein derivate therapeuticsPatrick Poulin
Journal of Pharmaceutical Sciences|May 7, 2015
A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug designPatrick Poulin
Journal of Pharmaceutical Sciences|September 12, 2024
An overview of interpretability of two models of unbound fraction that are used in combination with the well-stirred model for predicting hepatic clearance of drugsPatrick Poulin
Journal of Pharmaceutical Sciences|March 27, 2015
Drug Distribution to Human Tissues: Prediction and Examination of the Basic Assumption in In Vivo Pharmacokinetics-Pharmacodynamics (PK/PD) ResearchPatrick Poulin
Talanta|December 17, 2008
Determination of ammonium using a microplate-based fluorometric techniquePatrick Poulin, Emilien Pelletier
Journal of Pharmaceutical Sciences|May 15, 2013
Hepatocyte composition-based model as a mechanistic tool for predicting the cell suspension: aqueous phase partition coefficient of drugs in in vitro metabolic studiesPatrick Poulin, Sami Haddad
Regulatory Toxicology and Pharmacology : RTP|November 7, 2017
Integration of a plasma protein binding factor to the Chemical-Specific Adjustment Factor (CSAF) for facilitating the estimation of uncertainties in interspecies extrapolations when deriving health-based exposure limits for active pharmaceutical ingredients: Investigation of recent drug datasetsPatrick Poulin, Richard Arnett
Pageof 6